DXIV - ETF AI Analysis
Top Page
Dimensional International Vector Equity ETF (DXIV)
DXIV, the Dimensional International Vector Equity ETF, has a solid overall rating driven mainly by strong, diversified holdings in high-quality global companies like ASML and Novartis, which show robust profitability, positive growth outlooks, and supportive technical trends. Energy names such as Shell, TotalEnergies, and Suncor also add to the fund’s strength with stable financials and favorable momentum, while weaker positions like Bayer, with its financial and valuation challenges, slightly weigh on the rating. The main risk factor is the fund’s notable exposure to cyclical sectors like energy and materials, which can be sensitive to commodity prices and global economic conditions.
DXIV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 237.24M
- Region
- Developed Markets
- Expense Ratio
- 0.30%
- Beta
- 0.64
- Issuer
- Dimensional
- Inception Date
- Sep 12, 2024
- Dividend Yield
- 2.46%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
DXIV Summary
DXIV, the Dimensional International Vector Equity ETF, invests in a wide mix of companies outside the United States, across both developed and emerging markets. It doesn’t track a single index, but follows a global equity theme, focusing on stocks that the manager believes have attractive size, value, and profitability traits. The fund holds many well-known names such as ASML and Sony, along with energy, financial, industrial, and consumer companies from Japan, Europe, Canada, and more. Investors might consider DXIV for international diversification and long-term growth. A key risk is that its value can rise or fall with global stock markets.
How much will it cost me?
This ETF has an expense ratio of 0.30%, which means you’ll pay about $3.00 per year for every $1,000 invested. That’s a bit higher than the cheapest index ETFs because it’s actively managed using Dimensional’s strategy to tilt toward certain types of international stocks, which adds some extra management cost.
What would affect this ETF?
DXIV could benefit if developed markets outside the U.S. grow steadily, especially in sectors like energy, materials, and industrials, and if strong companies such as ASML, Nestlé, and Novartis continue to perform well as global demand and innovation increase. On the downside, slower economic growth abroad, falling commodity prices, stricter regulations on energy companies, or rising interest rates that pressure international stocks could weigh on the fund’s returns.
DXIV Top 10 Holdings
DXIV leans heavily on a mix of European health care, energy, and industrial giants, with a clear tilt toward developed markets outside the U.S. Suncor, BP, Shell, and TotalEnergies have been rising, giving the fund a strong energy engine that’s currently pulling returns higher. ASML and Sony add a tech and electronics flavor, though ASML’s recent wobble and Sony’s mixed year mean they’re not always firing on all cylinders. Meanwhile, steadier names like Roche, Novartis, and Nestlé help smooth out the ride, keeping the fund broadly diversified rather than dominated by any single stock.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 ASML | ASML Holding | 0.93% | $2.15M | $546.78B | 38.43% | 81Outperform |
 SHEL | Shell | 0.83% | $1.91M | $282.26B | 33.51% | 78Outperform |
 FR:TTE | TotalEnergies SE | 0.73% | $1.67M | EUR 177.97B | 49.76% | 78Outperform |
 AU:BHP | BHP Group Ltd | 0.68% | $1.57M | AUD 292.91B | 34.00% | 68Neutral |
 CH:NESN | Nestlé SA | 0.66% | $1.51M | CHF 220.83B | 8.82% | 71Outperform |
 NVS | Novartis | 0.63% | $1.44M | $296.68B | 28.43% | 80Outperform |
 SU | Suncor Energy | ― | ― | ― | ― | 77Outperform |
 BP | BP | 0.55% | $1.26M | $115.60B | 24.32% | 68Neutral |
 DE:BAYN | Bayer | 0.54% | $1.24M | EUR 54.60B | 109.66% | 54Neutral |
DXIV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DXIV, the sentiment is Negative. The current price of 70.87 is below the 20-day moving average (MA) of 71.95, below the 50-day MA of 72.67, and above the 200-day MA of 70.74, indicating a neutral trend. The MACD of -0.19 indicates Positive momentum. The RSI at 41.80 is Neutral, neither overbought nor oversold. The STOCH value of 42.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DXIV.
DXIV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| DXIV | $70.87 | $76.00(7.24% Upside) | $237.24M | 0.30% | 62Neutral |
 FYLD | $38.76 | $42.83(10.50% Upside) | $760.46M | 0.59% | 62Neutral |
 TXUE | $34.71 | $39.57(14.02% Upside) | $597.07M | 0.65% | 65Neutral |
 AVSD | $78.18 | $89.33(14.26% Upside) | $374.48M | 0.23% | 65Neutral |
 NBIE | $26.15 | $30.95(18.34% Upside) | $232.12M | 0.29% | 70Outperform |
 RINT | $31.26 | $39.42(26.13% Upside) | $167.03M | 0.49% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DXIV | Dimensional International Vector Equity ETF | 70.87 | 9.76 | 15.96% | |
| FYLD | Cambria Foreign Shareholder Yield ETF | 38.76 | 7.91 | 25.64% | |
| TXUE | Thornburg International Equity ETF | 34.71 | 4.08 | 13.32% | |
| AVSD | Avantis Responsible International Equity ETF | 78.18 | 7.47 | 10.56% | |
| NBIE | Neuberger International Core Equity ETF | 26.15 | 1.28 | 5.13% | |
| RINT | International Developed Equity Active ETF | 31.25 | 2.88 | 10.15% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.